Femme et Homme
- | Pays :
- United States
- France
- | Organes : -
- | Spécialités : -
Extrait
The primary purpose of this study is to identify the maximum tolerated dose(s) of neratinib in combination with temsirolimus in subjects with solid tumors. This study will also include a preliminary evaluation of efficacy, and assessment of pharmacokinetic (PK) parameters of the combination.
Critère d'inclusion
- Neoplasms ,Malignant Carcinoma